Skip to main
BLLN

Billiontoone Inc (BLLN) Stock Forecast & Price Target

Billiontoone Inc (BLLN) Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

BillionToOne Inc. has demonstrated impressive financial performance, reporting a 117% year-over-year revenue growth during its first quarter as a public company, alongside achieving its first positive net income of $1.5 million. The company's gross margins have markedly improved to 53% in 2024, reflecting effective scaling strategies, while impressive revenue figures from prenatal and oncology tests indicate strong demand and growth potential. Additionally, the company's innovative technology positions it well for significant future revenue growth, with projected compound annual growth rates exceeding 25% in the reproductive health sector.

Bears say

BillionToOne Inc faces potential challenges in maintaining its competitive edge due to concerns about the protection of its proprietary technology and rising denial rates from payers, which could impact revenue. Additionally, the company may experience slower-than-expected revenue growth from both its core prenatal tests and newly launched oncology tests, exacerbating financial pressures. The possibility of decreased reimbursement under the Clinical Laboratory Fee Schedule (CLFS) and difficulties in securing adequate payments from Medicare and state Medicaid programs further heightens the negative outlook on its profitability and revenue stability.

Billiontoone Inc (BLLN) has been analyzed by 6 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Billiontoone Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Billiontoone Inc (BLLN) Forecast

Analysts have given Billiontoone Inc (BLLN) a Buy based on their latest research and market trends.

According to 6 analysts, Billiontoone Inc (BLLN) has a Buy consensus rating as of Dec 25, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $137.83, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $137.83, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Billiontoone Inc (BLLN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.